Thinking "Green" When Treating "Pink Puffers" and "Blue Bloaters"-Reducing Carbon Footprint When Prescribing Inhalers

2023-02-17 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Holman, Harland T., Michael J. Bouthillier, and Frank Müller. "Thinking "Green" When Treating "Pink Puffers" and "Blue Bloaters"-Reducing Carbon Footprint When Prescribing Inhalers​." ​Journal of the American Board of Family Medicine, ​2023, , ​doi: 10.3122/jabfm.2022.220292R2. 

Documents & Media

Manuscript79.97 kBAdobe PDF

License

GRO License GRO License

Details

Authors
Holman, Harland T.; Bouthillier, Michael J.; Müller, Frank 
Abstract
The impact of man-made climate change is already affecting millions of people worldwide. The health care sector in the US is a relevant contributor, accounting for about 8 to 10% of national greenhouse gas emissions. This special communication describes the harmful impact of propellant gases in metered dose inhalers (MDI) on the climate and summarizes and discusses current knowledge and recommendations from European countries. Dry powder inhalers (DPI) are a good alternative to MDIs and are available for all inhaler drug classes recommended in current asthma and COPD guidelines. Changing an MDI to PDI can significantly reduce carbon footprints. The majority of the US population is willing to do more to protect the climate. Primary care providers can engage in this by addressing the impacts of drug therapy on climate change in medical decision making.
Issue Date
17-February-2023
Journal
Journal of the American Board of Family Medicine 
Organization
Institut für Allgemeinmedizin 
eISSN
1558-7118
Language
English

Reference

Citations


Social Media